Alameda, California, United States, August 2025 – Penumbra, Inc. (NYSE: PEN), the world’s leading thrombectomy company, has announced the promotion of Shruthi Narayan to President, effective September 1, 2025. She will continue to report to Adam Elsesser, who previously held the position of President and will remain as Chairman of the Board and Chief Executive Officer of Penumbra.
Shruthi Narayan, a seasoned industry leader with two decades of experience in the medical device sector, was most recently serving as President of Penumbra’s Interventional Business. In this role, she led the company’s day-to-day operations and oversaw growth strategies across both the Neuro and Vascular franchises.
She joined Penumbra in 2013 as a Product Manager in the Stroke Franchise, and later played a pivotal role in building the Peripheral Vascular Division, driving global commercialization of the company’s embolization and thrombectomy solutions. Prior to Penumbra, Ms. Narayan began her medical device career at Medtronic in 2006, holding diverse roles in engineering, regulatory affairs, and cardiovascular sales.
“Shruthi is a dynamic, seasoned leader whose passion for innovation and proven ability to inspire global teams make her the obvious choice for this critical role,” said Adam Elsesser, Chairman and CEO of Penumbra. “Her vision and focus on excellence will undoubtedly help sustain Penumbra’s exceptional growth and market leadership, expanding access to our life-saving technology to patients around the world.”
Speaking on her appointment, Ms. Narayan stated, “Penumbra has been at the forefront of blood clot care for more than 20 years, advancing the most innovative technologies to address conditions from head-to-toe like stroke and pulmonary embolism. I am honored to carry on and expand our legacy of innovation and look forward to continuing this paradigm shift in patient care.”
Ms. Narayan holds a B.S. in Electrical Engineering from Anna University, India, and a M.S. in Biomedical Engineering from the University of Southern California, with a specialization in Medical Device Commercialization.
About Penumbra, Inc.
Penumbra, Inc., headquartered in Alameda, California, is the world’s leading thrombectomy company. With a focus on developing cutting-edge technologies to treat complex medical conditions like ischemic stroke, pulmonary embolism, and acute limb ischemia, Penumbra’s broad portfolio includes Computer Assisted Vacuum Thrombectomy (CAVT) systems. The company’s innovations are deployed in more than 100 countries, empowering healthcare providers to deliver faster, safer, and simpler clot removal, ultimately improving patient outcomes and quality of life.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
